The shortly statement was directed at CU and the trial. Clearly things are taking longer then Leo was likely told. Last 10q statement said they would be receiving data late February so any day now.
"The Company will be providing shortly an update based on further data analysis of the Brilacidin Phase 2 COVID-19 study results and compassionate use of Brilacidin in critically-ill hospitalized COVID-19 cases".
Yes Covid-19 has been declared pretty much over but collaborative work with NIH and other researchers on Brilacidin’s broad-spectrum antiviral properties is ongoing according to Leo's January update and generating promising data, with future updates planned. I think this our strong suite. Still a lot of nasty viruses out there with a need for treatment.
News 
Market Data 
Discover 
